Patents by Inventor Sakino Toue

Sakino Toue has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7388030
    Abstract: The present invention provides a method for suppressing hemolytic anemia by selectively ameliorating reticulocyte increase and iron deposition on spleen caused as the side effects of methionine. The present invention also provides an appetite suppressor with reduced such side effects, where threonine is used as the effective ingredient of the suppressor of hemolytic anemia due to methionine and a combination of methionine and threonine is used as the effective ingredient of the appetite suppressor.
    Type: Grant
    Filed: May 24, 2004
    Date of Patent: June 17, 2008
    Assignee: Ajinomoto Co., Inc.
    Inventors: Yasuko Kawamata, Takeshi Kimura, Makoto Miura, Sakino Toue, Ryousei Sakai
  • Publication number: 20040214894
    Abstract: The present invention provides a method for suppressing hemolytic anemia by selectively ameliorating reticulocyte increase and iron deposition on spleen caused as the side effects of methionine. The present invention also provides an appetite suppressor with reduced such side effects, where threonine is used as the effective ingredient of the suppressor of hemolytic anemia due to methionine and a combination of methionine and threonine is used as the effective ingredient of the appetite suppressor.
    Type: Application
    Filed: May 24, 2004
    Publication date: October 28, 2004
    Applicant: Ajinomoto Co., Inc.
    Inventors: Yasuko Kawamata, Takeshi Kimura, Makoto Miura, Sakino Toue, Ryousei Sakai
  • Publication number: 20030018075
    Abstract: The present invention provides a method for suppressing hemolytic anemia by selectively ameliorating reticulocyte increase and iron deposition on spleen caused as the side effects of methionine. The present invention also provides an appetite suppressor with reduced such side effects, where threonine is used as the effective ingredient of the suppressor of hemolytic anemia due to methionine and a combination of methionine and threonine is used as the effective ingredient of the appetite suppressor.
    Type: Application
    Filed: May 31, 2002
    Publication date: January 23, 2003
    Applicant: Ajinomoto Co., Inc.
    Inventors: Yasuko Kawamata, Takeshi Kimura, Makoto Miura, Sakino Toue, Ryousei Sakai